This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Thierry, A.-C. Articles by Demotz, S. Search for Related Content PubMed PubMed Citation Articles by Thierry, A.-C. Articles by Demotz, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB BIOTIN Social Bookmarking                         What's this?

Biotinylated Synthetic Chemokines: Their Use for the Development of Nonradioactive Whole-Cell Binding Assays

Geneviève Perrenoud

Stéphane Pinaud

Nicolas Bigler

Bérangère Denis

Mario Roggero

Corinne Moulon

Stéphane Demotz

Dictagene, Lausanne, Switzerland.

A chemokine binding assay on whole cells was developed using biotinylated synthetic CCL22 as a model ligand. CCL22 analogues were produced by a chemical route, resulting in > 97% homogeneous and defined polypeptides. First, the 5 biotinylated CCL22 analogues synthesized were captured by agarose-immobilized streptavidin, indicating that the biotin molecules introduced in positions G1, K27, K49, K61, and K66 of CCL22 were accessible for binding. Then, it was established using a migration assay that the biotinylated chemokines were at least as biologically active as the unmodified CCL22 form. Subsequently, the biotinylated chemokines were evaluated in an FACS-based whole-cell binding assay. Surprisingly, only the CCL22 analogue with the biotin in position K66 constituted a suitable staining reagent for CCR4-positive cells. Finally, binding characteristics and reproducibility of the binding assay were outlined for the CCL22 analogue with the biotin in position K66. These results exemplified that biotinylated synthetic chemokines constitute promising ligands for the development of chemokine receptor-binding assays on whole cells, provided the position of the biotin moiety introduced along the sequence is adequately chosen. (Journal of Biomolecular Screening 2003:316-323)

Key Words: chemokines • whole-cell binding assays • CCL22 analogues • CCR4-transfected and untransfected cells

Journal of Biomolecular Screening, Vol. 8, No. 3, 316-323 (2003)
DOI: 10.1177/1087057103008003009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?